PFIZER Inc (PFE)

Pfizer, Inc. is one of the world's leading pharmaceutical companies, founded in the US in 1849. Today the company is actively developing two areas of business:

• Production of innovative drugs, including: Diflucan, Zitromax, Lyrica, Viagra, Celebrex and others.
• Investments in research of new medicines. It is a leading developer of a COVID-19 vaccine (Pfizer/BioNTech).

The development of the vaccine has led to significant interest in the company from investors, as well as to an increase in the value of the company's shares. Over the past year (as of early 2022), their value has increased 53%, and 91% since the beginning of the pandemic.

The company's position in the global market is very stable:

• Production facilities are located in 46 countries, including the US, UK, Italy, France and Turkey.
• Structural divisions are represented all over the world (100+ countries).
• 2021 revenue exceeds $69 bn.
• The market value of the company is $296.3 bn.

Pfizer shares are:

• listed in the prestigious S&P 500 index;
• traded on the New York Stock Exchange (NYSE), ticker PFE;
• The company consistently pays dividends, averaging about $0.3 per share.

How to buy Pfizer shares?

Just2Trade offers a single MT5 Global trading account with access to the world's leading exchanges, including the NYSE. To invest in PFE shares (or any other - more than 30,000 trading instruments are available in total), you only need to:

• Register with Just2Trade.
• Open a brokerage account and fund it.
• Select the necessary assets in the trading terminal and start trading.